Results 21 to 30 of about 119,702 (338)
The heterogeneity of Parkinson’s disease
Journal of Neural Transmission, 2023 AbstractThe heterogeneity of Parkinson’s disease (PD), i.e. the various clinical phenotypes, pathological findings, genetic predispositions and probably also the various implicated pathophysiological pathways pose a major challenge for future research projects and therapeutic trail design.
Ullrich Wüllner +7 more
openaire +5 more sources
Frontiers in Neurology, 2018 BackgroundAlthough bedrooms are identified as a major location for accidents among Parkinson’s disease (PD) patients, there are no studies that specifically evaluate the bedroom environments of PD patients.ObjectiveTo examine the physical bedroom ...
Roongroj Bhidayasiri +11 more
doaj +1 more source
Methamphetamine and Parkinson's Disease [PDF]
Parkinson's Disease, 2013 Parkinson's disease (PD) is a neurodegenerative disorder predominantly affecting the elderly. The aetiology of the disease is not known, but age and environmental factors play an important role. Although more than a dozen gene mutations associated with familial forms of Parkinson's disease have been described, fewer than 10% of all cases can be ...
Rosario Moratalla +6 more
openaire +5 more sources
Parkinson's Disease, 2015 Balance dysfunction (BD) in Parkinson’s disease (PD) is a disabling symptom, difficult to treat and predisposing to falls. The dopaminergic drugs or deep brain stimulation does not always provide significant improvements of BD and rehabilitative ...
Davide Ferrazzoli +7 more
doaj +1 more source
How to spot ocular abnormalities in progressive supranuclear palsy? A practical review
Translational Neurodegeneration, 2019 Background For parkinsonian disorders, progressive supranuclear palsy (PSP) continues to be significant for differential diagnosis. PSP presents a range of ocular abnormalities that have been suggested as optional tools for its early detection, apart ...
Onanong Phokaewvarangkul +1 more
doaj +1 more source
Simulation Study and At Home Diagnostic Tool for Early Detection of Parkinsons Disease [PDF]
arXiv, 2021 Hypomimia is a condition in the early stages of the progression of Parkinsons disease that limits the movement of facial muscles, restricting the accurate depiction of facial expressions. Also known as facial masking, this condition is an early symptom of Parkinson's disease, a neurodegenerative disorder that affects movement. To date, no specific test
arxiv
Risk of Parkinson Disease and Secondary Parkinsonism in Myocardial Infarction Survivors
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022 Background In addition to primary neurodegenerative processes, vascular disorders, such as stroke, can lead to parkinsonism. However, some cardiovascular risk factors, such as smoking and elevated cholesterol levels, are associated with reduced risk of ...
Jens Sundbøll +7 more
doaj +1 more source
Analysis, Identification and Prediction of Parkinson Disease Sub-Types and Progression through Machine Learning [PDF]
, 2023 This paper represents a groundbreaking advancement in Parkinson disease (PD) research by employing a novel machine learning framework to categorize PD into distinct subtypes and predict its progression. Utilizing a comprehensive dataset encompassing both clinical and neurological parameters, the research applies advanced supervised and unsupervised ...
arxiv +1 more source
Imaging in Parkinson's Disease [PDF]
Clinical Medicine, 2016 Parkinson's disease (PD) is a chronic neurodegenerative disease characterized by the loss of nigrostriatal dopaminergic neurons and aggregation of misfolded α-synuclein in Lewy bodies. The underlying mechanisms of neurodegeneration in PD are still unknown, and there are no disease-modifying treatments to slow the neurodegenerative processes.
Pagano, Gennaro +2 more
openaire +7 more sources
Small Molecule Chaperones for the Treatment of Gaucher Disease and GBA1-Associated Parkinson Disease
Frontiers in Cell and Developmental Biology, 2020 Parkinson disease, the second most common movement disorder, is a complex neurodegenerative disorder hallmarked by the accumulation of alpha-synuclein, a neural-specific small protein associated with neuronal synapses. Mutations in the glucocerebrosidase
Tae-Un Han, Richard Sam, Ellen Sidransky
doaj +1 more source